Impact of Mediterranean and Ketogenic Diets on Alzheimer's Disease
DOI:
https://doi.org/10.54097/ycwjkx45Keywords:
Alzheimer’s disease; Mediterranean Diet; Ketogenic Diet.Abstract
Alzheimer's disease (AD) is a neurodegenerative disease (NDD) characterized by cognitive decline and behavioral disorders. In recent years, the number of patients has been on the rise and the population is becoming increasingly younger, which has attracted widespread public attention. At present, research on the intervention of dietary patterns in AD patients is still in its early stages, but many animal and human experiments have shown that the Mediterranean diet (MD) and ketogenic diet (KD) can improve the pathological and physiological changes of AD patients, thereby slowing down the progression of related symptoms. However, the specific impact mechanism is still unclear. This article collects the relevant influencing factors and mechanisms of MD and KD on AD patients, and concludes that both different dietary patterns have significant positive effects on the treatment of AD patients. The purpose of this study is to reveal the pathogenesis of AD and deepen the public's understanding of AD. In addition, based on research results, scientific dietary guidelines can be developed for AD patients and susceptible populations to prevent and treat the occurrence and development of AD through dietary adjustments. Based on the fact that AD patients are mostly elderly, they have eating problems such as swallowing difficulties and anorexia. In addition to providing guidance on the dietary content of AD patients, teaching them how to adhere to a MD or a KD is also a crucial part of dietary therapy. Future research can also start from the implementation effect.
Downloads
References
[1] Alzheimer's disease International. World Alzheimer Report 2018: The state of the art of dementia research: new frontiers. [Online] Available at: https://www.alzint.org/u/WorldAlzheimerReport2018.pdf [Accessed: 9th Sep 2020].
[2] Guasch-Ferré, M., & Willett, W.C. (2021). The Mediterranean diet and health: A comprehensive overview. Journal of Internal Medicine, 290, 549–566.
[3] Lu, Y.Y., Fang, Z.Z., Fan, Y.Y., Wang, B.W., Zheng, R.M., et al. (2023). Progress in the pathogenesis and drug treatment of Alzheimer's disease. Progress in Physiological Sciences, (02), 81–89.
[4] Adalbert, R., Nogradi, A., Babetto, E., Janeckova, L., Walker, S.A., Kerschensteiner, M., et al. (2009). Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain, 132(Pt 2), 402–416.
[5] Chen, Z.Y., & Zhang, Y. (2022). Animal models of Alzheimer's disease: Applications, evaluation, and perspectives. Zoological Research, 43(6), 1026–1040.
[6] Liu, Y., Liu, F., Iqbal, K., Grundke-Iqbal, I., & Gong, C.X. (2008). Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer's disease. FEBS Letters, 582, 359–364.
[7] Dyńka, D., Kowalcze, K., & Paziewska, A. (2022). The role of ketogenic diet in the treatment of neurological diseases. Nutrients, 14(23), 5003.
[8] Liu, Y., Liu, F., Iqbal, K., Grundke-Iqbal, I., & Gong, C.X. (2008). Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer's disease. FEBS Letters, 582, 359–364.
[9] Maalouf, M., Rho, J.M., & Mattson, M.P. (2009). The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Research Reviews, 59, 293–315.
[10] Włodarek, D. (2019). Role of ketogenic diets in neurodegenerative diseases (Alzheimer’s disease and Parkinson’s disease). Nutrients, 11, 169.
[11] Bough, K.J., Wetherington, J., Hassel, B., Pare, J.F., Gawryluk, J.W., Greene, J.G., Shaw, R., Smith, Y., Geiger, J.D., & Dingledine, R.J. (2006). Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Annals of Neurology, 60, 223–235.
[12] Peixoto, L., & Abel, T. (2013). The role of histone acetylation in memory formation and cognitive impairments. Neuropsychopharmacology, 38, 62–76.
[13] McDonald, T.J.W., & Cervenka, M.C. (2018). Ketogenic diets for adult neurological disorders. Neurotherapeutics, 15, 1018–1031.
[14] Pierre, K., & Pellerin, L. (2005). Monocarboxylate transporters in the central nervous system: Distribution, regulation and function. Journal of Neurochemistry, 94, 1–14.
[15] Youm, Y.H., Nguyen, K.Y., Grant, R.W., Goldberg, E.L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T.D., et al. (2015). The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nature Medicine, 21, 263–269.
[16] Hu, Z.G. (2009). Experimental study on the protective effect and mechanism of ketogenic diet on traumatic brain injury. (Doctoral dissertation). Nanjing University, Nanjing, China.
[17] Svart, M., Gormsen, L.C., Hansen, J., Zeidler, D., Gejl, M., Vang, K., Aanerud, J., Moeller, N. (2018). Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: Reduced glucose uptake, unchanged oxygen consumption, and increased blood flow by positron emission tomography. PLOS ONE, 13(2), e0190556.
[18] Mu, J., Wang, T., Li, M., Guan, T., Guo, Y., Zhang, X., Zhang, G., & Kong, J. (2022). Ketogenic diet protects myelin and axons in diffuse axonal injury. Nutritional Neuroscience, 25, 1534–1547.
[19] Guasch-Ferré, M., & Willett, W.C. (2021). The Mediterranean diet and health: A comprehensive overview. Journal of Internal Medicine, 290, 549–566.
[20] Stefaniak, O., Dobrzyńska, M., Drzymała-Czyż, S., & Przysławski, J. (2022). Diet in the prevention of Alzheimer's disease: Current knowledge and future research requirements. Nutrients, 14(21), 4564.
[21] Román, G.C., et al. (2019). Mediterranean diet: The role of long-chain ω-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao, and wine; probiotics and vitamins in prevention of stroke, age-related cognitive decline, and Alzheimer's disease. Rev Neurol (Paris), 175(10), 724–741.
[22] McGrattan, A.M., McGuinness, B., McKinley, M.C., Kee, F., Passmore, P., Woodside, J.V., & McEvoy, C.T. (2019). Diet and inflammation in cognitive ageing and Alzheimer's disease. Current Nutrition Reports, 8(2), 53–65.
[23] Yassine, H.N., et al. (2023). Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias. Alzheimer's & Dementia, 19(3), 1041–1066.
[24] Palimariciuc, M., et al. (2023). The quest for neurodegenerative disease treatment—focusing on Alzheimer's disease personalized diets. Current Issues in Molecular Biology, 9, 45(2), 1519–1535.
[25] Naureen, Z., et al. (2022). Dietary supplements in neurological diseases and brain aging. Journal of Preventive Medicine and Hygiene, 63(2-3), E174–E188.
[26] Grant, W.B., & Blake, S.M. (2023). Diet's role in modifying risk of Alzheimer's disease: History and present understanding. Journal of Alzheimer's disease, 96(4), 1353–1382.
[27] Walsh, D.M., & Selkoe, D.J. (2004). Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron, 44, 181–193.
[28] Soodi, M., Saeidnia, S., Sharifzadeh, M., et al. (2016). Satureja Bachtiarica ameliorates beta-amyloid-induced memory impairment, oxidative stress, and cholinergic deficit in an animal model of Alzheimer's disease. Metabolic Brain Disease, 31, 395–404.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Highlights in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
